<SEC-DOCUMENT>0001558370-17-000058.txt : 20170109
<SEC-HEADER>0001558370-17-000058.hdr.sgml : 20170109
<ACCEPTANCE-DATETIME>20170109073011
ACCESSION NUMBER:		0001558370-17-000058
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170109
DATE AS OF CHANGE:		20170109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AxoGen, Inc.
		CENTRAL INDEX KEY:			0000805928
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				411301878
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36046
		FILM NUMBER:		17515796

	BUSINESS ADDRESS:	
		STREET 1:		13631 PROGRESS BLVD.
		STREET 2:		SUITE 400
		CITY:			ALACHUA
		STATE:			FL
		ZIP:			32615
		BUSINESS PHONE:		(386) 462-6817

	MAIL ADDRESS:	
		STREET 1:		13631 PROGRESS BLVD.
		STREET 2:		SUITE 400
		CITY:			ALACHUA
		STATE:			FL
		ZIP:			32615

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LECTEC CORP /MN/
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>axgn-20170109x8k.htm
<DESCRIPTION>8-K
<TEXT>
<!--HTML document created with Merrill Bridge  6.3.135.0-->
<!--Created on: 1/9/2017 6:21:50 AM-->
<html>
	<head>
		<title>
			axgn_Current Folio_8K_20170109
		</title>
	</head>
	<body><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p style="margin:0pt;border-top:3pt double #000000 ;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 13pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:13.5pt;">UNITED STATES </font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 13pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:13.5pt;">SECURITIES AND EXCHANGE COMMISSION </font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">Washington, D.C. 20549 </font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 18pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:18pt;">Form 8-K</font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;">Current Report </font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 12pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:12pt;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 </font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">Date of Report (Date of earliest event reported):&nbsp; January 9, 2017</font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 18pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;font-size:18pt;">AXOGEN, INC. </font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">(</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exact name of registrant as specified in its charter)</font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:32.00%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">Minnesota</font></p>
				</td>
				<td valign="top" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:32.00%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">001-36046</font></p>
				</td>
				<td valign="top" style="width:01.90%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:32.00%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">41-1301878</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:32.00%;padding:0pt;">
					<p style="margin:0pt;text-indent: -12.25pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">(State or other jurisdiction of</font><font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;<br /></font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">incorporation)</font><font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:32.00%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">(</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Commission File Number)</font></p>
				</td>
				<td valign="top" style="width:01.90%;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:32.00%;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">(IRS Employer</font><font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Identification No.)</font><font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:50.42%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">13631 Progress Boulevard, Suite 400,<br />Alachua, Florida</font></p>
				</td>
				<td valign="top" style="width:02.98%;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:46.60%;border-bottom:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">32615</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:50.42%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">(Address of Principal Executive Offices)</font><font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:02.98%;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:46.60%;border-top:1pt solid #000000 ;padding:0pt;">
					<p style="margin:0pt;text-align:center;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">(Zip Code)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Registrant&#x2019;s telephone number, including area code</font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 55.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:100.00%;border-bottom:1pt solid #000000 ;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">(386) 462-6800</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:100.00%;border-top:1pt solid #000000 ;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">(Former name or former address if changed since last report,)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 12pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;">&#x2610;</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> &nbsp; &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;">&#x2610;</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> &nbsp; &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;">&#x2610;</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> &nbsp; &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;">&#x2610;</font><font style="display:inline;font-family:Times New Roman,Times,serif;"> &nbsp; &nbsp;</font><font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </font>
		</p>
		<p style="margin:0pt;border-bottom:3pt double #000000 ;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			&nbsp;
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;color:#000000;font-size:10pt;">Item 2.02&nbsp; Results of Operations and Financial Condition</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">On January 9, 2017, AxoGen, Inc. (&#x201C;AxoGen&#x201D;) issued a press release announcing its estimated fourth quarter and full year 2016 revenue.&nbsp; A copy of the press release is furnished as Exhibit&nbsp;99.1 to this Current Report.</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;color:#000000;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;color:#000000;font-size:10pt;">The information furnished pursuant to Item 2.02 of this Current Report, including Exhibit&nbsp;99.1 hereto, shall not be considered &#x201C;filed&#x201D; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#x201C;Exchange Act&#x201D;), or otherwise subject to the liability of such section, nor shall it be incorporated by reference into future filings by the Company under the Securities Act of 1933, as amended, or under the Exchange Act, unless the Company expressly sets forth in such future filing that such information is to be considered &#x201C;filed&#x201D; or incorporated by reference therein.</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">Item 9.01. Financial Statements and Exhibits&nbsp; </font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">(d)<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;;font-size: 10pt;font-family:Arial,Helvetica,sans-serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font>Exhibits</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:13.94%;padding:0pt 5.8pt 0pt 5.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:05.56%;padding:0pt 5.8pt 0pt 5.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:80.50%;padding:0pt 5.8pt 0pt 5.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:13.94%;border-bottom:1pt solid #000000 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exhibit No.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:05.56%;padding:0pt 5.8pt 0pt 5.8pt;">
					<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:80.50%;border-bottom:1pt solid #000000 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:13.94%;border-top:1pt solid #000000 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">99.1</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:05.56%;padding:0pt 5.8pt 0pt 5.8pt;">
					<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:80.50%;border-top:1pt solid #000000 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">AxoGen, Inc. press release, dated January 9, 2017.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;"></font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt -18pt 0pt 0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;color:#000000;">SIGNATURE</font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:24.5pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:50.82%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:04.18%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:45.00%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">AXOGEN, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.82%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:04.18%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:45.00%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.82%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Date: January 9, 2017</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:04.18%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">By:</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:45.00%;border-bottom:1pt solid #000000 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">/s/ Gregory G. Freitag</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:50.82%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:04.18%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:45.00%;border-top:1pt solid #000000 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">Gregory G. Freitag</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:50.82%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:04.18%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:45.00%;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">General Counsel &amp; Senior VP of Business Development</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;"></font>
		</p>
		<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;text-indent:24.5pt;text-align:center;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;">EXHIBIT INDEX</font>
		</p>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:13.94%;padding:0pt 5.8pt 0pt 5.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:05.56%;padding:0pt 5.8pt 0pt 5.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:80.50%;padding:0pt 5.8pt 0pt 5.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;height:1.00pt;overflow:hidden;font-size:0pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:13.94%;border-bottom:1pt solid #000000 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Exhibit No.</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:05.56%;padding:0pt 5.8pt 0pt 5.8pt;">
					<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:80.50%;border-bottom:1pt solid #000000 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:13.94%;border-top:1pt solid #000000 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">99.1</font></p>
				</td>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:05.56%;padding:0pt 5.8pt 0pt 5.8pt;">
					<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:80.50%;border-top:1pt solid #000000 ;padding:0pt 0pt 0pt 0pt;">
					<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
						<font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;">AxoGen, Inc. press release, dated January 9, 2017.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;color:#000000;font-family:Arial,Helvetica,sans-serif;font-size: 10pt;">
			<font style="display:inline;font-family:Times New Roman,Times,serif;">&nbsp;</font>
		</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>axgn-20170109ex99128d8f4.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Merrill Bridge  6.3.135.0-->
<!--Created on: 1/9/2017 6:21:54 AM-->
<html>
	<head>
		<title>
			axgn_Current Folio_Ex99_1_20170109
		</title>
	</head>
	<body><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p style="margin:0pt;text-align:right;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-weight:bold;font-size:12pt;">EXIHIBIT 99.1</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 10pt;">
			<font style="display:inline;"><img src="axgn20170109ex99128d8f4001.jpg" style="width: 2.127388in; height: 0.6775525in" alt="axogen-inc-logo.jpg"></font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 11pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:11pt;display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 16pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:14pt;display:inline;font-family:Calibri;font-size:16pt;">AxoGen, Inc.&nbsp;Preannounces&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 16pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:14pt;display:inline;font-family:Calibri;font-size:16pt;">Estimated Fourth Quarter and Full Year 2016&nbsp;Revenue</font>
		</p>
		<p style="margin:0pt;text-align:center;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 9pt;">
			<font style="display:inline;font-family:Calibri;font-size:9pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:14pt;display:inline;font-family:Calibri;font-weight:normal;font-style:italic;font-size:12pt;">Q4 Revenue will be at least $11.3 &nbsp;million, representing 45% growth over prior year</font>
		</p>
		<p style="margin:0pt 0pt 0pt 36pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:14pt;display:inline;font-family:Calibri;font-weight:normal;font-style:italic;font-size:12pt;">2016 Revenue will be at least $41.0&nbsp;million, representing 50% growth over prior year</font>
		</p>
		<p style="margin:0pt;text-align:left;border-top:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 10pt;">
			<font style="display:inline;font-family:Calibri;">&nbsp;</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-weight:bold;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">ALACHUA, FL &#x2013; January&nbsp;09, 2017 &#x2013; </font><font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">AxoGen, Inc. (NASDAQ: AXGN), a global leader in innovative surgical solutions for peripheral nerve injuries, &nbsp;today announced preliminary unaudited fourth quarter and&nbsp;full year 2016&nbsp;revenue and selected business highlights&nbsp;for the quarter and year ended December 31, 2016.</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-weight:bold;font-size:12pt;">Preliminary&nbsp;Revenue and Selected Business Highlights</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;border-bottom:1pt none #D9D9D9;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-size:12pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;margin:0pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">Fourth quarter revenue is expected to be&nbsp;at least $11.3&nbsp;million, up 45% compared to the fourth quarter of 2015 revenue of $7.8 million </font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="border-top:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;border-top:1pt none #D9D9D9;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-size:12pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="border-top:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;margin:0pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">Full year 2016 revenue is expected to be at least &nbsp;$41.0 &nbsp;million, up 50% compared to 2015 revenue of $27.3&nbsp;million</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:115%;text-align:left;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;line-height:115%;text-align:left;punctuation-wrap:word-break;text-justify:inter-ideograph;font-size:12pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:115%;text-align:left;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;margin:0pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">Ended the quarter with 51&nbsp;direc</font><font style="display:inline;font-family:Calibri;font-size:12pt;background-color:white;">t sales representatives and 20 independent distributors</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="line-height:115%;text-align:left;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;line-height:115%;text-align:left;punctuation-wrap:word-break;text-justify:inter-ideograph;font-size:12pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="line-height:115%;text-align:left;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;margin:0pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;background-color:white;">Completed 13 national education courses in 2016 and expects to conduct 15 courses in 2017</font></p></td></tr></table></div>
		<div style="width:100%"><table style="width:100%;" cellpadding="0" cellspacing="0"><tr><td style="width:18pt;"><p style="width:18pt;font-size:0pt;"></p></td><td valign="top" align="left" style="width: 18.00pt; display: inline;">
			<p style="text-align:left;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;margin:0pt;">
				<font style="margin:0pt;font-family:Symbol;text-align:left;punctuation-wrap:word-break;text-justify:inter-ideograph;font-size:12pt;;"> &#xB7;</font>
			</p>
		</td><td style="width:0pt;"><p style="width:0pt;width:0pt;font-size:0pt;"></p></td><td align="left" valign="top">
			<p style="text-align:left;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;margin:0pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;background-color:white;">The number of peer reviewed clinical publications for our surgical portfolio increased by five to a total of 44 </font></p></td></tr></table></div>
		<p style="margin:0pt;line-height:115%;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">"We are pleased to report another successful quarter including record revenues of at least $11.3 &nbsp;million representing at least 45 percent growth over the prior year,&#x201D;&nbsp;stated Karen Zaderej, President and Chief Executive Officer. &#x201C;This performance continues to&nbsp;validate our growth strategies and reflects the continued adoption of our product portfolio.&nbsp;We are well positioned to continue to drive awareness and growth in the emerging peripheral nerve repair market during 2017.&#x201D;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-weight:bold;font-size:12pt;">2016 Financial Guidance </font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;background-color:white;">Management increases its full year 2016 revenue guidance to at least $41.0 million from its previous estimate of over $40.0 million. Management reiterates its full year 2016 gross margin guidance to exceed 80%.</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-weight:bold;font-size:12pt;">2017 Financial Guidance </font>
		</p>
		<p style="margin:0pt;line-height:115%;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;background-color:white;">Management reiterates 2017 annual revenue will grow at least 40% over 2016 revenue and gross margins will remain above 80%.&nbsp;&nbsp; </font>
		</p>
		<p style="margin:0pt;line-height:115%;border-top:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:left;punctuation-wrap:word-break;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-weight:bold;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 10pt;">
			<font style="display:inline;"></font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 10pt;"><font style="display:inline;"></font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-weight:bold;font-size:12pt;">Upcoming Investor Event </font>
		</p>
		<p style="margin:0pt;line-height:115%;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">Members of the AxoGen senior management team will participate in The Trout Group Annual 1-on-1 Management Access Event in San Francisco, January 9&#x2013;11, 2017. To request a meeting, please contact </font><font style="display:inline;font-family:Calibri;font-size:12pt;">axogenevents@troutgroup.com</font><font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">.&nbsp; </font>
		</p>
		<p style="margin:0pt;line-height:115%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:115%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">The results disclosed in this press release are preliminary and unaudited. The Company will report full, audited results for the fourth quarter and year ended December 31, 2016&nbsp;on February 22, 2017.</font>
		</p>
		<p style="margin:0pt;line-height:115%;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:115%;border-top:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-weight:bold;font-size:12pt;">About AxoGen,&nbsp;Inc.</font>
		</p>
		<p style="margin:0pt;line-height:115%;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">AxoGen Inc. (AXGN) is a global leader in innovative surgical solutions for peripheral nerve injuries. AxoGen&#x2019;s portfolio of products includes Avance&#xAE; Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard&#xAE; Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves, AxoGuard&#xAE; Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments and&nbsp;Avive&#x2122; Soft Tissue Membrane, a minimally processed human umbilical cord membrane that may be used as a soft tissue covering to reduce inflammation and scar tissue formation.&nbsp; Along with these core surgical products, AxoGen also offers AxoTouch&#x2122; Two-Point Discriminator and AcroVal&#x2122; Neurosensory &amp; Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation, assessing return of sensory, grip and pinch function, evaluating effective treatment interventions, and providing feedback to patients on nerve function. The AxoGen portfolio of products is available in the United States, Canada, the United Kingdom, and several European and international countries. </font>
		</p>
		<p style="margin:0pt;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:115%;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-weight:bold;font-size:12pt;">Cautionary Statements Concerning Forward-Looking Statements</font>
		</p>
		<p style="margin:0pt;line-height:115%;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">This Press Release contains "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations or predictions of future conditions, events or results based on various assumptions and management's estimates of trends and economic factors in the markets in which we are active, as well as our business plans. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "projects," "forecasts," "continue," "may," "should," "will," &nbsp;and variations of such words and similar expressions are intended to identify such forward-looking statements. The forward-looking statements may include, without limitation, statements regarding our growth, our 2016 and 2017 guidance, product development, product potential, financial performance, sales growth, product adoption, market awareness of our products, data validation, our visibility at and sponsorship of conferences and educational events. The forward-looking statements are subject to risks and uncertainties, which may cause results to differ materially from those set forth in the statements. Forward-looking statements in this release should be evaluated together with the many </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr><p style="page-break-after:always">&nbsp;</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><p style="margin:0pt;line-height:115%;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;"><font style="display:inline;font-family:Calibri;font-size:12pt;">uncertainties that affect AxoGen's business and its market, particularly those discussed in the risk factors and cautionary statements in AxoGen's filings with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and actual results may differ materially from those projected once audited financial statements are finalized. The forward-looking statements are representative only as of the date they are made and, except as required by law, AxoGen assumes no responsibility to update any forward-looking statements, whether as a result of new information, future events or otherwise.</font>
		</p>
		<p style="margin:0pt;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-weight:bold;font-size:12pt;">Contacts:</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">AxoGen, Inc.</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">Peter J. Mariani, Chief Financial Officer</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">InvestorRelations@AxoGenInc.com</font><font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">The Trout Group &#x2013; Investor Relations&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">Brian Korb </font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="font-family:Calibri;font-size:11pt;display:inline;font-family:Calibri;font-size:12pt;">646.378.2923</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">bkorb@troutgroup.com</font><font style="display:inline;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;border-top:1pt none #D9D9D9 ;punctuation-wrap:word-break;text-align:justify;text-justify:inter-ideograph;font-family:Batang;font-size: 12pt;">
			<font style="display:inline;font-family:Calibri;font-size:12pt;">&nbsp;</font>
		</p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;">
		<p><font size="1"> </font></p></div><div style="margin-left:10.2941176470588%;margin-right:10.2941176470588%;"><hr align="center" style='background-color:#000000; border-width:0; color:#000000; height:2pt; lineheight:0; width:100%;'></hr></div>
	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>axgn20170109ex99128d8f4001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 axgn20170109ex99128d8f4001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" "5 =0# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BL7Q]\1=#^%OAF?6/$6J6>D:;;CYY[A]JY[*!U9CV4 D]
MA7PO^TK_ ,%;M2UM[C2OAO:G2[3E#K%Y&&N9/>*(Y5!Z%LG!Z*:][).&\?FL
M^7"P]WK)Z17S_17?D?*\3<9Y5D5/GQ]3WGM!:R?HNB\W9>9]K_%7XX^$O@EH
M_P!N\4Z]I^CPL"8UFDS--CKLC&7<^R@U\F_&#_@L=I]@\MKX&\,RW[+D+?:L
M_E1'W$*'<P^KJ?:OE/X8? _XC?MB>-9[BPAU+7+F60"\U?4)F,$!_P"FDS9Y
M _A7+8Z"OMW]G[_@E'X+^'4<-]XOE;QAJRX8PN#%81'T$8.Z3'JYP?[HK[FI
MD/#V1+_A4J.M5_DCHON3T_[>:OV/R^AQ5Q?Q1*V1TEAJ'_/R6K?HVG?TC%V?
MVCYC3]JO]H;]J#4I+7P]>:])&S8:+0+3[-%!G^],HW*/=Y*ZK0?^"9OQJ^*.
MVX\5>(;731)RZZEJLM[<?DF]3_WW7Z):+HVG^&-,AL=/M;/3[.W&V*"WB6*.
M,>@50 /PJX#FO*K<?5*7N97AJ=&/^%.7WZ+\'ZGO8;PGI5_WF>8RKB)]4Y-1
M^Z[?XKT/A30O^"-%]IY65OB6;2X'.;71V^4_[WG@_I7;^'?V+_C;\'-LGA#X
MSG4UC^[9:S;RFV8?W<,TP7/JH!]Z^M**\FOQMFU?3$SC-=I0@U_Z3^I[^&\-
M,@POO8.G.E+^:-6HG_Z7;\#QCX=_M$^)O#>IV^B?%?PROA>_N'6&VUJRD^T:
M+?R$X5?,R3;NQX"R'YCT.2!7L^<U#J.FV^L6$UK=V\-U:W"&.6&5 \<BD8(8
M'@@CL:AT+18O#VEQV=NTIM[<;8ED<N8U[+D\D#H,Y.*^?Q=:C6?M*<.1]4K\
MOJKW:]+M=K;'U>7X;$8=>RJU'4CT<K<WI*R2EY.R?>[U+E%%%<9Z04444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7A/[
M7'[>7AG]F"SDT^/9KGBR1,Q:9%)\MOD</.P^XO<+]YN. #N'E'[<O_!2N'P,
M]YX1^'MS#=:RN8;[6$P\5B>A2'LT@[MRJ].3G;\*>$O"/B'XU>/(=-TNWOM<
MU[6)BV-QDDE<G+.[L>!U+,QP.237ZAPKP#[>"Q^;>Y2W47HVN\G]F/XOR6_X
M=QWXK?5JCRK(?WE=OE<DKJ+VM%?:E^">FKNEM?&CX^>,/VE?&2W_ (BO[C4+
MB1]EI90J1!;;C@)%$.F>!GEFXR2:]_\ @7_P3^T;P'X:A\;?''5K?PSH:XD@
MT>6;RKBY[@2D?,"1_P LX\N>Y4@BL+2?'?@?]A2W:/0TTWQ]\50I2?5&_>:5
MH#D8*0]#+(.A88^HY0^"_$[XM>)/C+XFDUCQ-J]YJ]])G#S/\L0Z[44?*B_[
M*@"OTKV6*QE-8;+_ /9\.M.9*TI+^XOLK^\]7NEU?XS[? Y=6>,S?_:\6W?D
M<KPB_P#IY+[<E_)'W5M*5]%]B?$C_@J[HGP]T=/#_P )_"-I!I]DOE075[%Y
M%N@]8[>,@D'KEF4YZK7S?\1?VW?BI\3YI#J/C/6+>%_^7?3Y/L4('IB+;N'^
M]DUY3179EW"N5X+6G24I=92]Z3?>[V^5CS<XX\SS,O=K5W&&RA#W(I=K1M=+
MSN6K_7;[5)S+=7EU<2,<EY96=C^)-;_@?XW^,?AK=I-H/B?7-*:,YVV]XZQM
M[,F=K#V((KEJ*]RIAZ52'LYQ379I-?<?,4<57I5/:TIN,NZ;3^]:GWS^QY_P
M5.D\2ZS:>&_B5]EAFNF$5MKD2"*-G/ %P@^5<G^-<*.,@#+5]O@[AD5^$]?J
M%_P2^_:%N/C+\"7T?4[AKC6?!\B6;R.VYYK9@3 Q/J K)_VS!ZFOQ?Q X/H8
M2G_:6!CRQO:45LK[-=E?1K;56/Z3\)?$3%8^M_8V:3YYV;A)[NV\7W=M4][)
MW;T/I:BBBOR4_?0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ****  G KX)_X*"_\%$VU&6^\"_#^^*VJ[H-5UB!^9CT:&!A
M_#U#..O0<<G0_P""DG[>C6+7WPZ\%WNV;F'6]1A;E.S6T;#OV=AT^[UW8^%]
M&TB;7-02WAVAFR6=SM2)1R68]E Y)K]CX&X)CRQS3,EIO"+_ /2I?HOF^A_.
MOBAXES<Y9)DTM=JDUWZPB_PD_DNI>\"^!K_XA:^NGV"Q*VPS3SSN([>SA7EY
M97/"(HZD^P&20#W?B/XRV/PW\*77A/X>R30VMXGE:QX@*&*]UOUC3O#;>B#Y
MF'+GG:.2\0^,8K/06\/Z(SQZ27#W<Y7;+JLJ]'?N(U_@CZ#J<L2:YFOU66&^
ML24Z_P *U4?/HY=WV6RW>MK?@\,9]3@Z>%?OM6E-;I/>,7T3VE+=[*T;\Q11
M17H'DA1110 4444 %?5W_!(+Q;)HW[2.I:7N_P!'UG1I05]9(Y(W4_@OF#_@
M5?*-?1W_  2K@:7]K_3&7[L6GW;-]/+Q_,BOG>+:<9Y-B5+^1O[M5^*/K^ :
MTZ?$>"E#?VD5\F[/\&S]2J***_ED_ND**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "OEO_@HY^VK_ ,*'\+GPGX;N@/%VLPYD
MFC/S:5;MQO\ :1N0H[#+?W<^N_M3_M%:;^S+\([[Q%>;)KQO]'TVT)P;NY8'
M:O\ NC!9CV53WP#^0GCGQOJGQ(\7ZAKNLW4E[JFJ3-/<3/U9CZ>@ P !P  !
MP*_2. .%%CZWU[%+]U!Z)_:E_DNO=Z=S\:\6./'E6&_LS R_?U%JUO"+Z^4I
M;+LKO1V,N21II&9F9F8Y))R2:L'4#!I[6\/RK-@S-WEQR%_W1UQW/)Z#%6BO
MW_E3/Y.4FM@HHH'-,D**]E^'O[%NOZSX73Q-XPO['X>>$3@C4=9RLUP.N(+<
M?O)&(Y X##H32ZI\4?AC\*,V_@CPD?%FH1\'7/%8\R(GN8K)2(]O<&4L?45Y
M+SBE.;I81.K);\OPKUD[1OW2;EY'O1X?K4Z:KXZ2HQ>JYK\TEWC!)RL^C:47
M_,>5^&_!FL>,;GR='TG4M5F'5+.U>=OR4$UU;?LL?$Q+;SC\/O&GE@9)_L:X
MS^6S-0>,/VC/''CF'R+[Q)J2V(X6QM)/L=G&/18(ML8_!:Y73/$.H:)?K=6=
M]>6=TIW+-#,T<@/J&!S6W^W25_<B^VLOQ]W\CG_X3(2M^\FN_NP_\EM/_P!*
M&ZUH5]X;U&2SU&SNK"[B^_!<PM%(GU5@"*JU]N?L@>(XOV^OAMXB^'OQ$"ZM
MK6B6@NM'UV1 U_;*3L.9.K;7*'D_.&(;. :^,_%OAFZ\%>*M3T:^7R[W2;N6
MSN%'\,D;E&'Y@URY9FSQ%>K@Z\>6K3M=)W335U).RT?5-73T._.N'UA,+0S'
M#3YZ%:_*VK24HNTHR5VKKHT[-:HSZ^O?^".7A-M2^.GB/667=%I6C& '^[)-
M,F/_ !V)Z^0J_2;_ ()"?#5O#'P"U3Q%-'MF\3ZB?*;'WX( 8U_\B&:O%\0,
M8L/DE5=9VBOF]?P3/H_"?+7B^):#MI3YIOY*R_\ )FCZRHHHK^:S^T HHHH
M*S]?\6:7X4BC?5-2L--28E8VNKA(0Y'4 L1FM"ORW_X*5?M!?\+I^/UQIME/
MYFA^$=VGVVT_++-G]_)^+ )[B,'O7TG"_#L\XQ?U=/EBDW)VO;M\V_U?0^,X
MYXPI\.Y?];<>><FHQC>UWNW?71+RWLNI^DG_  N+PC_T-/AW_P &4/\ \55C
M3?B?X:UF^CM;/Q#H=U=3';'##?1222'T"ALFOQ+KT3]D?6O^$?\ VG_ -SNV
MC^W;2)CZ"254/Z-7WV+\+J5*A.K'$-N*;MRK6ROW/RG+_'*OB,53H3PD4I2B
MF^=Z)M*_P]#]C****_'3^B0HHHH **** "BBB@ HHHH **** "BBB@ H9@@R
M> .YKY\_;]_X*.^!?^"?_@-+S7I&U;Q-J4;'2?#]K(%N;TCC>YY\J$'@R$'N
M%#'BOQ$_;"_X*C_%_P#;/U*ZC\0>([C2/#4K$1>'](D:UL$3L) #NF/O*6YS
M@*.*=A-G[O?$O_@H#\$?@_>26OB+XI>";&\A)$EJNJ1SW$9]&BC+./Q%<79?
M\%@OV:]0NO)C^+&@JQ.,R6]S&O\ WTT0'ZU_.713Y1<Q_4M\*/VAO ?QVM&F
M\%^,O#/BJ.-=T@TO4HKIHA_MJC$K_P " KLJ_E'\*^+-4\#>(+75M%U*_P!'
MU2Q<26]Y97#V\\##^)74AE/N#7[(?\$9/^"P.I?M':Y#\*OBA>17'B_R6;0]
M:*B-M95%+-!,!@>>J@L&  =5;/S#+CB"D?I11114E!1110 4444 %%%% !11
M10 4444 %%%% !1110 4RXN([.WDFE=8XHE+N['"JHY))[ 4^OE+_@JG^TF?
MAA\*(_!NEW'EZSXN1EN"I^:"R'#_ $\P_(/5?,]*]+)\KJYCC*>#H[R>_9=7
M\EJ>+Q%GE#*,NJYAB-H*]N[V27J[+\3Y _;M_:AF_:9^,MQ/:3/_ ,(SHA:T
MTF+/RNN?GG(_O2$9]E"#J#7B=%%?U5E^!HX/#PPM!6C%67^?J]WYG\(YMFF(
MS'&5,=BG><W=_P"2\DM$NB5@HHKV_P#8[_8DU[]JG7_M!,FD^$[.3;>:DR<R
M$=8H0>&DQU/1<Y/928_,,/@J$L1B9*,8[M_UJ^R#*LIQ>98J.#P4'.<MDOS?
M1)=6]$<%\$?@'XH_:%\7)H_A?39+R;@SSM\MO9H?XY'Z*.O')., $\5]%:ZO
MPQ_X)ZQ_9;6&S^)'Q9A&7FN%SIVAR?[F?O@]!G?QDF/.#N_M%?M2Z/\  K15
M^#_P,M%M[@RBTO\ 5+/]Y-).V$,<;]7F)X:3^'HN",K\7:I$T&I7"23+<2+(
MP>56WK(V>2&[@GOWKYG#QQ6<OVN*O2P[U5.]I37>;6JB^D5OU;1]MC)X'AQ>
MQP-JV*6DJK5X4WUC33TE)=9M:?92>W0?%KXT>)OCEXIDUCQ1JUUJEXV0@<XB
MMU_N1H/E1?8 >IR>:Y>BBOKJ-&G2@J=**C%;)*R7HC\_Q&(JUZCK5Y.4I.[;
M=VWYMA1179? ;X&ZY^T-\2+'PWH4)::X.Z>=E/E64((W2N>RC/U)( Y(J<17
MIT:<JU5\L8J[;Z)%87"UL36CA\/%RG)I)+=M[(^NO^"-/PQN(6\7>,IHV2UE
M6/2;5B/]80?-E_+]U^9]*^4?VJ-6AUS]I;Q]=6Y5H)O$%Z48=' G<;A]<9_&
MOT\\87.A_L-_LD7G]F!8[7PSIQBL_,QNN[M^$+>K/*VYL=,GL*_(FYN9+RXD
MFE=I)96+N[')9B<DGZU^>\&XF>99EC,WM:$K0CZ+];6;\V?KOB-@Z>2Y+E_#
M]TZD5*I/UE^EW)+RBBQX>T&Z\4Z_8Z78PM<7VHW$=K;Q+UDD=@JK^)(%?M1\
M'OAS;?"+X6Z!X9M-IAT6RCM=X'^M=5^=_JS;F/N:_/?_ ()0? 1OB%\:IO%U
M[#NTOP@FZ$L/EDO) 0@]]B[F]CL]:_2ROD_%#.%6Q4,OIO2FKR_Q/9?)?F?>
M^!W#KP^!JYM56M5\L?\ #%ZOYR_])04445^5G[L%%%% 'D/[;WQ^7]GC]G_5
M=4MYA'K.H#^S]+&?F$\@/SC_ '%#/Z94#O7Y'.[2.S,2S,<DD\DU]'_\%-OV
M@?\ A<'QZDT6QF\S1?!^ZQBVGY9;DD>>_P"# )_VSSWKR?\ 9P^#\_QX^-GA
M_P +PA_*U&Y'VIU_Y96Z?/*V?4(K8]R!WK^A^"LKAE.4/%8C24USR?:*5TOD
MM?5L_D'Q*SRKG_$*P.$]Z--^S@N\F[2?SEI?LDSAZV/AYK/_  COQ T/4-VW
M[#J%O<9]-DBM_2KWQJT*'PM\9/%NEV\:PV^FZU>6L<:C"QJD[J%'L ,5S.:^
MVC*->BGTDOS1^9SC/"XAQZPE^*?_  #]T**R_ VL?\)%X*T?4,[OMUE#<9]=
MZ*W]:^=?VEO^"D0_9J^+5]X5OO!-SJ'V>.*>"[34Q$MS&Z@A@IB.,-N7J>5-
M?RIE^3XO'5WAL+#FFKNUTM$[/=H_O#-N(LORO"QQN/J<E.323M)ZM77PIO9>
MA]/45\1_\/GK#_HGUY_X.%_^,U[5^QW^VY8?M;W.NV\.B2Z#=:*L,GE278N/
MM"2%P6!"+C:5 /\ O"O2QW".;8.A+$XFCRPCN[Q=KNW1M[L\?*_$#A_,<5'!
MX+$*525[+EFKV3;U<4MD^I[E15;6=8M?#VD75_?7$5K9V<33SS2MM2)%&68G
ML  37QMKO_!931;'6KN&Q\$WU]90S,D%RVI+"9T!P'V>4=N1SC)QFN+*\AQ^
M9<WU*FY<N^J5K^;:/2SWBK*LFY/[2K*GSWMHVW;?2*;MY['VE17R9\%_^"GU
MU\=OB/IWAG0_AQ>27E^_S2-JX\NVC'WY7/D\*HY]^ ,D@5]-^.OB!HOPQ\,W
M&L>(-2L])TVV'[R>XDVKGL!W9CV R3V%3F&28W UHX?$PM.6R33;Z;1;WZ=R
MLHXFRS,\//%X*KS4X:.34HI:7>LDEHM^W4V**^,_BK_P6%T#1;N6V\(>&[W7
M-IVB\OIOLD+>ZH SL/\ >V&O,;G_ (+$?$!Y\P^'?!\<>>%>&X=OS\X?RKWL
M+P#G=:'/[+E7]YI/[KW7S2/E<=XL<,X:HZ?MW-K^6,FOOM9_)L_1JBOA+X>?
M\%DI_ML<?BOP?#]G8_/<:5<D/&/:*3(;_OL5]A_!_P"-7AOX[^$(];\,:E%J
M%FYV2 ?++;OW21#RK#T/4<C((->3FW#699:N;%TVH]U9K[U>WSL>_P /\:9-
MG3<,OK*4EJXM.,ON:5UYJZ.JKR#]N3]L'0?V'_V>-8\<:YMN)H1]ETK3P^V3
M4[UP?+A4]AP69N=J(QP< 'U^OP)_X+C?MIR_M1?M<7OAS3+LR>$/AQ)+I-DJ
M-F.YNP0+JX]#EU\L'D;8@1]XUX:/J&?+WQ\^//B?]ICXL:QXT\8:C)J6N:U,
M9)7/$<*]$BC7^"-%PJJ.@'<Y-<=17Z*?\$$/^">&G_M$?$"_^*7C+3X[[PKX
M-NEM]+LYTW0ZCJ( <LX/#)"I1MIX9W3J%8&R#RW]E;_@A_\ &_\ :A\*VOB#
M[#I/@K0;Y!+:W/B&:2":[C/1XX$1Y-IZ@N$##D$BH_VQ_P#@BE\8/V._ %SX
MMNSH?BWPS8#??7>B2R/)IZ=/,EBD16">K)N"CEL#FOZ"AQ537M"L_%&AWNF:
MA;PWFGZC ]K<P2KNCGB=2KHP[@J2"/0U/,5RG\H5;?PU^(.I_"?XAZ'XHT6=
MK75O#U_#J-G*#]R6)PZ_AD#([BKOQO\  *_"GXT^+_"ZLSKX;UN]TH,W5A!.
M\63_ -\UR]42?U7?#?QO:_$SX=Z#XDL<_8O$&G6^I6^3G]W-$LB_HPK:KQ7_
M ()OWLM_^P)\'))LEQX0TV/GT6W15_0"O9;Z^ATNRFN;F:*WM[=#)++*X1(U
M R68G@  9)/2LS0EHKX)_:L_X."OA'\"]4NM)\&V=]\3-8MB4>6PF6UTM&'&
M/M+!C)]8XW4_WJ^3_$?_  <P?%:ZOF;2? ?P]L;;/RQW8O+J0#W99HP?^^13
MY6*Y^TU%?D5\&O\ @YIU:+5X8?B%\-=.GL78"6Z\/7CPRPCN5AF+!_H95^M?
MI;^S!^UEX#_;#^',?B?P%KD.K6.X1W,)'EW5A+C/E31'YD;]&'*DCFE89Z11
M17YP?M%?\'$6A_ ;X[^+O!,/PQOM=7PGJL^E/?IKR0+<O"YC<A/(;;\RL/O'
MI0!^C]%?E;_Q$]Z1_P!$;U+_ ,*5/_D:OLKXK_\ !2WX?_L\?LS^$?B%\099
M/#][XQTBWU2Q\.6[B\U*9I85E,2+\@;9O :1MB \$@D E@N?1%%?CQ\5/^#F
MGQ=>:M*O@GX:^'=.L58B-]<NYKR:0>I6$Q!2?0,V/4U!\+_^#F?QM9:U#_PF
MGPY\+ZEIK,!*=%N)[*=%[E1*TRL1Z';GU'6GRL5T?L=17FG[*'[6G@O]L[X2
M6OC'P/J#76GRN8+FWG41W6G3@ M#,F3M< @\$@@@@D$&O2Z0PHHHH AO[Z'2
M[&:YN)$AM[=&EDD<X5% R23Z "OQO_:E^-T_[0GQRUWQ-(TGV2XF,-A&W_+&
MU3Y8EQV)'S'_ &F:OT,_X*>?&5OA7^S)>V%M-Y>I>+)1I46#\PA(+3M]-@V?
M]M!7Y8U^V>%N3J-*IF4UK+W8^BW?S=E\F?S/XZ<1.>(I9-2>D5SS_P 3TBOD
MKO\ [>0445Z5^RM^S;JO[3_Q5M=!L=]O8Q8GU*]VY6S@!Y/NS?=4=R?0$C]4
MQ6*I8:C+$5WRQBKM^1^%8' U\;B(87#1<IS:22ZM_P!:OHM6=A^P]^Q5J'[4
MWBTWE]Y]CX/TN4"^NU&UKENOD1'^\1C)_A!]2 ?H3]OW]K73_@!X/B^$WPY$
M&EW$5L(+Z6S^4:7 1Q"A'/FN#EFZ@-G[S97V+]HOXIZ!^P3^S%#:>'[6WMKB
M./\ L[0[/KOF(),K]VV\NQ/WB0"<M7YD^ /"NJ_'SXQZ9I+7$UUJWBC4E2:Y
MD.]RTCYDE;UP"S'Z&OS7*Y3X@Q4LWQ_NX6BWR1>S:WE+O;KTOILG?]HSR-/A
M/ PX?RI\V.Q"7M9K=*6BA%]+O;K;WGJU;W;]FG]GJ;PE^RIX\^+U_ WVQ-+N
M++P^K#F+?^YENQ[C<RJ>V'/H:^7Z_;*3X1Z')\)&\$?8POAYM-_LGR <$0>7
MY?7^]CG/7//6OSK^+W_!*?XD^"_$%POAJVM?%>DER8)HKF.WN%3L)$D91N_W
M2P^G05PKQMA,3B,1+&S5.4I)QYG9<J5E&[TNMWW;;1''?AIC\%@\)#+:3JQA
M!J?*FW[1N\I66K3T2T=E%)]#YAHKZ$\)?\$O?C#XFNUCN-!L=%B8X\Z^U&':
M/PB+M_X[7TA\"_\ @D/X;\*7$-]XXU:;Q+<(0WV&U!MK,'T9L^9(/IL]P:^D
MS+C;)\'&[K*;[0]YO[M%\VCXS)_#/B+,)J,</*G'K*HG!+Y/WG\DSXW_ &;_
M -E#Q=^T[XC6UT&R:+387"WFJ7"E;6T'?+?Q/CHBY)]ADC]1/V9_V8/#?[+W
M@==)T.+SKRXP]_J,JCS[Z0=S_=49.U!P >Y))[KPWX9T[P=HEOINDV-IINGV
MJ[(;:VB$440] J\"OFO_ (*(_MOP_ CPU-X3\-W2OXRU2'$DD;9_LB%A]\^D
MK#[HZC[Q_A#?D^9<09EQ1BHX#"QY:;?P^2^U-]EOV72[L?OF2\)Y-P/@)YMC
MI<]5+XFNK^S37=[7W>MVE=+Y_P#^"J'[4L?Q.\?0^!M%N?-T7PQ,6O9(VRES
M>X*D>XB!*_[S/Z U\HZ/I%UX@U:UL+*"2ZO+V9(((8QEI9&(55 ]22!43"2<
M/*VYN?F8GJ3[^IY_6OL__@D]^RTWB+Q')\2M:M_]!TMVM]&21>)KCH\V/1 =
MH/\ >)[I7ZQ4GA.&LF]W:"LN\I/_ #>ODO)'X%1IX_C/B/WM'5=WVA!?I%:+
MO+S9]??LG_ 6W_9Q^!VC^&XQ&U\J?:=1F7_EO=/@R'/<#A1_LHM>D445_->*
MQ53$5I5ZSO*3;;\V?VE@<%1P>'AA<.K0@E%+R2L@HHHKG.H*\I_;/^/B_L[_
M  #U?6HI%75KI?L.EJ>IN9 0K8[[%#.?]S'>O5J_,?\ X*@_M _\+7^.A\.V
M,WF:/X-W6GRGY9;LX\YO^ D!/8HWK7U7!V2?VGF4*4U[D?>EZ+I\W9>ESX7Q
M%XF_L7):E:F[59^Y#U?7_MU7?K9=3YIFF>XF:21FDDD)9F8Y9B>I)K[U_P""
M0/P._L_0M<^(%Y#^\U!CI>FEATB4AIG'LSA5S_TS;UKX8\)>%[SQOXIT[1].
MB,U_JES':6\?]Z1V"K^IZU^SOPB^&]G\'_AEH?AG3P/LNBVB6X8#'FL!\[GW
M9BS'W8U^H>)6<?5\!'!4W[U5Z_X5O][LO2Y^&^"W#WUS-99E57N4%IYSE=+[
ME=^3L?DQ^U[8_P!G?M2_$&/&-VOWDO\ WW*S_P#LU><U[!^WS8_V=^V!XZCQ
MC=?++_WW#&__ +-7C]?<9/4Y\!0GWA%_^2H_+^(J?L\UQ5/M4FONDS]D/V4=
M9_M_]F;P#=;MS-H-FC'U9(51OU4U\R?\%BOA-]KT/POXVMXOGLY&TF\8#DH^
M9(2?8,)!]7%>W_\ !.K6?[;_ &-_!DF[+0Q7%N?;R[F51^@%=9^U1\*1\:OV
M?O%/AU8Q)=7EDTEH,?\ +Q'B2+\W51]":_GW XW^R^(W4>BC4E%_X6VG^&I_
M7&99;_;G!T:*5Y3HPE'_ !**DOO:M\S\;Z^AO^"8?Q'_ .$"_:NTNUDD\NU\
M26TVER9/&XCS(_Q+QJH_WJ^>F4HQ5@0P."#VJUH.O7GA?7+/4M/N)+2^T^9+
MBWGC.&AD0AE8>X(!K^A,TP*QN#JX5_;BUZ-K1_)ZG\BY#FDLMS&ACX_\NY*5
MNZ3U7S5T?9?_  5$_;$_M[4)OAKX;NLV5FX_MVXB;B>4'(M@?[J'!?U8 <;3
MGXPTS3;C6=1M[.TAEN;JZD6&&&)2SRNQPJJ!R220 *BGGDNIWEE=I))&+.['
M<S$\DD]R:^^/^"8?[&7]@V5O\2O$]I_IMTF=#M95_P!1&1_Q\D'^)APGHI+?
MQ#'SM2I@N%LHLM6MN\YO^ODD?8T:69<<\0.4M$]WNJ=-=/\ +^:3OI=GH7[,
M/P,T']@7]GS4O%7BJ2&/6I;876KW PS0C^"TB]?F(''WG/H%Q\'?M/?M0^(/
MVG_'DNIZK-);Z; [+IVFHY\FRC[<?Q.1C<YY)]  !]"_\%=?CY)JWB[2_A[8
MS$6FEHNH:D%/^LG<'RD;_=0[L=#Y@]*^+ZX>"\IG5B\[QWO5JVJO]F/2W:Z_
M\ELNYZ?B3GU.C./#.5^[AL/HTOMSW?-WL]_[UV^EG11-/*L<:L\CD*JJ,EB>
M@ KKO%'[/OCKP1X976M8\(^(M,TIL9NKFPDCC3/3<2/ESVSC-?4'_!)']GJS
M\4:YJWC_ %2U2XCT646.E"1=RK<%0TDO^\BE #VWD]0*^ZO'7A^S\6>"M6TN
M_C2:QU"SEMYT<95D9"#^AKEXA\05E^8?4J--24;<SOWZ+T7?KI;0[N$?".6;
MY1_:6(K.FYI\B23VT3E?HVMETUOJ?B+7LG[#/[0=W^S_ /'O2;C[0Z:'K4R:
M?JL)/[MHG;"R$>L;'<#UQN'\1KQN@'!K] QV#IXO#SPU97C)-/\ KRW7F?DV
M5YE6P&+IXW#NTX--?+IZ/9]T?K7_ ,%!OVB_^&4_V.?'GC:&58M1TW36@TPG
M_G]G(A@..^V216(]%-?S/3SO<S/)(S222,69F.68GDDGUK]=?^#A_P"/,S?L
ML?!_PBLQ\[Q=+_;UX >62WMT50WLSW1/UC]J_(BOY*E!PDXOH?W_ $ZBJ04X
M[-)_> YK^F+_ ()[?L\Q_LM_L;> ?!OD+!?V6EQW.IC&&:]G_?3Y]<2.RC/9
M0.U?S]_L"_"-?CK^VC\,O"TD?G6NI>(+5KN/&=]M$_G3#_OU&]?TU5$C2(45
M\F?ML?\ !8OX:_L*?&*'P3XHT7QEK&K2:=%J32:/;6TL,*2/(JHQEGC;?^[W
M8 (PR\]0/(/^(E?X)_\ 0G_%+_P!L/\ Y+J;%7,?QS_P;IZ5\7?CEXP\9^)O
MBAJ*Q^*]=O=8-AINCI$UN+BX>;9YTDKAB-^,^6.G2O1?A_\ \&]/[/'@[RSJ
M5KXP\5,O+?VEK)B5OPMEA./QKDO^(E?X)_\ 0G_%+_P!L/\ Y+KKO@-_P7Q^
M%/[1'QE\->!]"\(_$B/5O%%_%I]M)<V=DL$3.<;W*W3,$498D*3@'@U6I.A]
MC>#_  EH/P4^&VGZ+I<-OHOAGPOIZ6UM&\Q\JRM84P,NY)VJB\LQ)XR3WK\/
M?^"M?_!7'6/VP/%U_P""?!-]=:7\+=-F,1,3&.3Q(ZG_ %TO0^3D92(]>&8;
ML!/LK_@X8_;1G^#GP+TWX6Z%=M;ZW\0E:75'C;#P:6APR>H\Z3Y,]"D<JGK7
MXFT1[A)@JEV  R3P .]?1GA+_@DA^T=XW\#Q^(M/^%6O-IDL7G)]HGMK6YD3
M&05MY9%F.1TPG/:O>_\ @WS_ &,]/^/7[0NK?$#Q%8QWVB?#E87LH)DW1SZE
M*6,3D'AO*5&?'9VB/:OW!H;!(_E#U_0+[PKKEYIFJ6=UIVI:?,UO=6MS$T4U
MO(IPR.C %6!!!!&017L?_!/O]LW6_P!A_P#:2T7Q9I]Q/_8LTR6FOV*D^7J%
MBS#S%*]-ZC+H>H91V)!]M_X.!_"NF^&_^"BNIS:?%'#-K&AV%]>A!C=/M>+<
M?<I%'GUZU\1U1)_5KJGB_3])\&W.O27"-I=K9-?M.ARIA5#(6!]-HS7\L'CO
MQ=<_$#QQK.O7AS>:W?3W\YSG,DLC2-^K&OW7^*OQNF\'?\$%8?$T\S+>7WPR
MT_3/,)^9IKNVAL]P]]TN:_!*IB5(=&5#KN!*YY ."17:_'[X[^(OVF/BC>>)
MO$$[SW5PJP6MLA)ATZUC&V*VA7^&.-< #OR3EB2<GX2_#74OC+\4?#OA'1TW
MZIXFU*WTRU!'RB2:18U)_P!D%LD]@":_I7_96_9 \"_L?_##3?#7@_0[&T^R
MP)'=ZAY"_;-3E ^:::3&YF8Y.,X48    #;$E<_F'/%%?HY_P<D^ O#GA+]I
MCP3?Z3IMCI^KZYH<L^J-;1+&;LK.5CDD"@;G^^NX\D*!G &/SCIB/TF_X-G_
M !UJ5E^U%X]\,QS2?V3J7A8ZG-%GY3/;W=O'&V/7;<RBOVBK\=?^#9'P,]]\
M8_BCXFV?N]+T:TTS=CO<3M)C_P E?Y5^Q51+<N.P4444AGYL?\%>/B:WBCX_
MZ;X<CDW6WA?3EWIG[L\^)&_\AB&ODZO0OVL?&3>/OVEO'&J%MZS:Q<11-ZQQ
MN8H__'$6N#L+";5;Z&UMH9)[BYD6**)%W-([' 4#N22!BOZNX=P:P>5T*&W+
M%7]7J_Q;/X,XOS*68YYB<5OS3:7HGRQ_!(T/"7A.X\47A6&&:6.-TCVQKEYI
M7.V.%/5W;@#DX#'!"FOUF_8S_9GM?V9/A!;Z:T<)U[4L7>KSISNF(XC4_P!R
M,?*/7ENK&OG']@#]FVVE^,,SS)'<:=\-#Y=Q*,-'>Z[(O[T@_P 2VR_NU_V@
M'&-YKZV_:,^(3?"GX$>+/$,3;+C2],FEMS_TV*E8_P#Q\K7Y/QYG]3'XB&58
M9^ZVK^;?PI_)I_-)JZ/WGPJX4HY7A*N?8U>\E)+R4;\[7S3C?LFT[2/S6_X*
M,?']_CC^T5J$%M.9-#\+LVEV*@_(S*<32C_>D!&1U5$K8_X)2>'8=<_:XL[B
M50S:3IEU=Q9_O$+%_*4U\VN[2NS,Q9F.22<DFO5_V)OCC;?L^_M%Z'KVH,RZ
M3)OLK]E&2D,HVE\?[+;6(')"D5^F9AE+HY#4R_!K54W%=WIK\Y:_-GXOE.?+
M$\4T<VS%Z2JQE)O9+F5OE'3Y(_8"BJ^DZM:Z[IEO>6-Q#=V=T@EAFA</'*A&
M0RL."".XJQ7\O--.S/[AC)-76P45Q?Q>_:&\&? G2VNO%'B"PTSY=T=N7WW,
MW^Y$N7;Z@8'<BOA']J?_ (*GZ]\3X+G1? L=SX9T63,<EZS :A=+[%3B$'_9
M);_:'(KZ/(^%<PS6:]A"T.LGI%?YOR5SX[BCCS*,BIOZU4YJG2$=9/U7V5YN
MWE=Z'OW[;_\ P43TWX%6MWX;\)S6^J>,6!CEE&)+?2#W+]FE'9.@/+?W6_.:
MUMM:^+7C=LR7&J:SJTS3333R99VY9Y)';@* "S,Q 4 DX J+P9X+UCXE^*[3
M1]%L;G5-6U&39%#$-S.QY))Z #DEC@  DD"O4/$?AJ/P3<1_#'P3M\1>+M;E
M6SUW4K/YEGDW _8+9O\ GBC &23C>R\X1<']RR?)\'D=+ZMAK2JR5Y2?9;RE
MVBNBOJ]+[M?R]Q#Q%F/$]?Z[C;QH0=H0CUD]H1_FF_M2MHM;6Y8NK\"OV?YO
MVD?C)I_@WP]([:-9'S=1U,1D#RP0);C!Y^;A8U./X<@$N:_6CP1X,TWX=>$=
M.T/2+9+33=*@6VMXE_A51CGU)ZDGDDDFO-_V-_V6-/\ V6/A9'IJ^3<Z]J&V
M?5KQ1_KI<<(IZ^6F2%'?EL L:]<K\=XSXE_M/$JE1;]C3^'^\^LGZ].R[79_
M1?AOP6LDP3KXF*^L5;.5OLKI!>G7N^KLF%%%%?%GZ0%%%% 'F/[8'QXC_9V^
M VL:^LBKJ4B?8],0_P#+2ZD!"<=PH#.1Z(:_(&YN9+VYDFFD>6:9B[NYRSL3
MDDGN2:^G?^"IG[07_"S_ (UKX7L)M^C^#MT#[3\LMXV/-/OL 5.>A5_6OEZO
MZ*\/\C^HY:JU1>_5M)^2^RONU^9_'OBUQ-_:F<O#TG>E0O%=G+[;^]6](WZG
MUI_P27^!W_":?&"^\97D.ZQ\*1;+8L.'NY00"/79'O/L60U^CE?BYX$^//C3
MX8:1)I_AWQ1KFBV4DIG>"SNWA1G( +$*>N% S["MO_AL'XI_]% \6?\ @RE_
MQKR>)N!\?FV.EBO;14;)13OHE\NKN_F?0<$>)V59!E<<#]7G*=W*37+9R?SZ
M))?([+_@IAI_V']LWQ4W:YCLY1_X"0C^:FO!:U?&?CG6/B)KTFJ:]J=[J^HR
MJJ/<W4IEE8*, %CSP.*RJ_0<KPLL+@J6&F[N$8QNNMDD?D>>X^&.S*OC:2<8
MU)RDD]US-NS^\_3C_@D[K/\ :G[**P9S_9NL75O],A)?_:E?3!YKX[_X(W:Q
MY_PB\7:?G_CUUA+C'IYD*K_[2_2OK+Q?XMT[P'X8OM9U:ZCL=-TV%KBXGD.%
MC11DG_ #DG '-?SAQ=AY1SO$4XK5RO;_ !6?ZG]D>'^+C/AG"5INRC"S;V2C
M=?A8_)S]N7X3_P#"G?VGO%&FQQ^78WMQ_:5G@87RI_GP/96+I_P"O)*]/_:Y
M_:.N?VG?C%=>()(?LNGVZ"STV @;XK=68KO(ZLQ9F/7!; X%>85_1F31Q$<#
M1CB_XBBE+UM^??S/X[XBJ82>:8B> =Z3G)QZ:-WT\NW6UKGT5_P3H_93M?VC
M/B=<:CK)AD\.^%FBFNK4L-U[(Y8QQD?\\SL8L>X&T=21^H1,5A:_P0PPI_NJ
MB@?H *_,/_@EQ\6O^%=_M-6^ESR;+'Q9;MI[@GY1,/GA/UW*4'_72OT"_:H\
M5MX)_9O\<:DC;);?1KE8F_NR/&40_P#?3"OQ?Q"IXNMG<,/4?NR45!=%=V?S
MYKW\K'](>$-; 8;AFKC*4??BYNH^K<5=?+E:LMKW[L_);XW?$27XM?%[Q)XD
ME9F_MC4);B/=U6,L1&O_  % H_"N6HJUHNE2Z]K-I8P#=->3)!&/5F8*/U-?
MNE*G"C25..D8JR\DD?R[6K5,37E5GK*;;?FV[_F?K)^P-\/U^'7[)O@^V*;9
M]0M/[4F..6:X)E7/T1D'_ :[CXY^)1X-^"WBW5BVW^SM'N[@'W6%B!^)P*WO
M#VC0^'-!L=/MUVV]C;QV\0]%10H_05XA_P %+?&__"&?LA^(8U?9/K4D&FQ>
M^^0,X_[]H]?R[A^;,LXBWO5J)_\ @4M?N1_<F+Y,FX=DH[4*+2]8PLOO:/RJ
MI41I'"J"S,<  =325W7[,?@9OB3^T)X-T54\Q+S58#,N/^62,))/_'%:OZBQ
M->-&C*M/:*;?HE<_AS!X6>)Q$,/3WG)17JW9'G?_  <$^)Y)?VN/"?A??^Y\
M&^#+"R*9^[,[RR.?Q4Q#_@-?"-?7_P#P7<NI+C_@IUX^1CE8+?2T3V']G6[?
MS8U\@5_(TI.3YGU/]!8P4(J$=EH?<W_!O/X 7QC_ ,%#K?4F3=_PBOAZ_P!3
M4D?=9_+M?SQ<G]:_>*OQD_X-F+.-_P!I#XC7#8\Z/PU'&GKM:Z0M^JK7[-U$
MMS6.Q_.?_P %A_B;_P +4_X*/?%"\63S(-+U%-%B&<B/[)"ENX'_ &TCD/U)
MKYGK][?'7_! ?X%_$7QMK'B#5+KQY-J>O7T^HW;KJ\8#S32-(Y \GNS&OSV_
MX+0?L)?"K]@W5/ NB^ Y?$$VM>((KJ]U!=2OUN!#;H8TB*@(N-SF7GG_ %=-
M,FQ\-U]J?\$!OAE_PL#_ (*,Z'J#1^9#X1TF^UA\C@$Q_9E/X/<J1[BOBNOU
M _X-V-"C\ ^#_CM\4KJ(>5X=T>*U@<]&5$GNIUS_ -LH/SIL$?*?_!7/X^2?
MM"_\% /B#J2S&;3M#OCX?T\9RJ0VF86V_P"R\HED_P"VE?-=6-5U2XUO5+F]
MNI&FNKR5IYI&ZN[$LQ/U))JO0(^K/V'?^"N?CW]@;X57WA+PCX9\$ZA9ZEJ;
MZI<7.J6US)<O(T<<>W,<Z+M"Q+@8ZD\\U[-_Q$K_ !J_Z$_X7_\ @%??_)5+
MX8_X-N?BQXD\-:?J+>-/ =FU_;1W)MYFN_,@WJ&V-B$C<,X..,BKW_$,_P#%
MC_H?/AY_WU>?_&:6A6I\5?M=_M4^(OVSOCMJGQ \46^FV>J:I%!";;3T=+6!
M(HEC4('9V&=NXY8_,QZ#@>9U^D/_ !#/_%C_ *'SX>?]]7G_ ,9IT/\ P;/_
M !5,J^9X]^'XCR-Q4WA;'?'[GK1="LSTC_@JIXK?X3_\$5/@/X+W>7>>(+/0
MX;B,\;HX-/\ .D_*;R?SK\E*_2[_ (.2_&EO8?%+X4?#^R8):>%?#TM\L2GA
M!/*L" _1;/\ 7WK\T:$#/L[_ (()?"I?B5_P49\/7DT7G6_A#3;W6W!&5!$?
MV>,GZ27",/=17[]5^1__  ;&_#+SM>^*WC*6/_CW@L=&MGQUWM+-,/P\N#\Z
M_7"E+<J.Q^!__!P!\3?^$_\ ^"BVL:<LGF1>#]'L='7!^4$QFZ;\=UR0?I[5
M\3UZC^VW\3?^%R?M?_$SQ,LGFPZMXDOI;9LY_<"9EB'X1J@_"O+JH@_;K_@V
MY^&7_"+_ +&_B3Q+)'MF\4^))%C;'WX+>&-%_*1IQ7Z'5\\?\$G_ (9?\*E_
MX)V_"G2VC\N6ZT5=6D!'S%KQWN^?<"8#VQBOH>H>YH@HHHI ?A?J^H-JVJW5
MT_+W4KRM]6))_G7M7['_ (33PQHGC#XK7T:M9_#^QSIHD&5FU2;]W;<'KY;,
M'/H=AKQOQ+H[^'O$>H:?("LEC<R6[ ]BC%3_ "KZ\^-GP_\ ^%._\$YOAOX;
MV_9[SQIK=OJ.I'H7\V-Y #[JOD+_ , K^I,_QD8TJ.$@_P"-)1_[<WG_ .2J
MWS/X9X4R^<Z^(Q]1?[M"4_\ N)?EA]TVI?\ ;K/K+]AGX8_\*L_9C\,VLRM_
M:&JP?VO?NWWY)KC]X=Q[LJE5_P" 51_X*)64U_\ L:>.$MU9I%MX)#C^XMS$
MS_\ CH->S6=M'96D4,2A(X4"(HZ* , 52\7>%K/QQX5U+1=1B\[3]6MI+2XC
M_OQNI5A^1-?SE3S27]IQS&KJ_:*;_P# KV_0_L:MD<?[$EE%%V7LG33]8\M_
MU9^'%%>I?M0?LG>)OV8?&=Q9ZE:SW&BR2D:?JJ1DP72?P@GHLF.J'G(.,C!/
MEM?U1@\91Q5&-?#R4HRU37]?AT/X3S#+\3@<1+"XN#A.+LT_ZV[/9K5'=?"_
M]IOQ]\&+7[/X9\5:MI=KDL+99!+;@GJ1&X9 3Z@<UO\ BC]NKXN>,+5H;SQW
MK21L,'[(4LR1]854_K7DU=I\*OV=O&WQLNUB\,>&]4U1&;:;A8O+MD/^U*V$
M7\6KBQ>!RR#>*Q-.FGUE)1_-K]3TL!FF=5(K X*M5:>BA&4[?**?Z'(ZAJ5Q
MJU[)<W5Q-=7$S;I)97+NY]23R3]:[_\ 9Y_9<\7?M+^(_L?AVP;['"P%WJ,X
M*6EF/]I\<MZ*N6/IC)'U/\&O^"5.B_#[26\2?%OQ!9BSL4\^>QMIS#:Q*/\
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M/$.M74/EZIXR<7[DCYEMP"(%^A4LX_ZZU^\\4<01R?!?6$DY-I16U^_R2O\
M@?RKP+PG/B+,_JDI.,$G*4EJTMEOU;:^5WT/SZ_X9A^)7_1//'/_ ((;K_XW
M1_PS#\2O^B>>.?\ P0W7_P ;K]EZ*_-O^(K8O_GQ'[V?L_\ Q ? ?]!4_P#P
M&)^(OC#P%KOP\U&.S\0:+JVAW<T8F2#4+.2UD="2 P5P"5R",],@UDU]A?\
M!8^Q\OXR>$[G_GMHS1Y_W9W/_L]?'M?J^0YE+,,!3QDE9S5[+IJU^A^"<59+
M'*<UK9="3DJ;LF]W=)_J?;__  1BUGR]7^(&GEO];#97"C_=,ZG_ -#6N0_X
M*5?ME_\ "W/$\G@?PY=;O#.C3?Z;/$WRZG<J>Q[QH>G9FR>0%-> ?"KXX:Y\
M&]+\2P:'-]EF\3:?_9LUPI(D@C+JS%#V8@%<]@Q(YP1QU>-2X5IRSRKF]?7X
M>1=FHI.3^[3[^Q]'B..JL>&*'#^%NOB]H^Z<VU%>3O>7E9=S0\*>%=1\<>)+
M+2-)LYK_ %+4)5@M[>(9:5ST'^)/ &2>*HR1M#(RLK*RG!!&"#7Z,?\ !,W]
MCG_A5WAB/QWXBM=OB+6H?^)?!*OS:=;,/O$=I)!R>X7 X)85\>_MO_#'_A4W
M[4/BW38X_+M+B[.H6N!A?+G'F@#V4LR_\!K;+>*L/C<TJY=1U4%?F[M.TK>2
MNK=]>ECFSK@7%Y9D>'S?$Z.K*SC_ "IJ\+^;M)M=-%O<\U\,^(;KPCXCT_5K
M&3R;W3+F.[MW'\$D;!E/X$"OT\_;'\?0?$?_ ()Y:YXBT_\ X]]:TRRND .2
MBR7$!93[C)!]P:_+6ON?]C/6I?V@?V _'WP[#&;5="@F%E%U9TD#3P#_ +_)
M(/88KS..,%&^%S)_\N:D>;_"Y*_W-+[V>YX8YE/EQV3+_F(HSY5_?C&5DO5-
M_<CX8KO/V6M+36OVE/ -M(,QR>(+'>#_ ! 3H2/QQBN#(VG!X(ZBM;P#XQNO
MAWXYT?7[':;S1;V&^A#?=9XW#@'V)&#[5]IC*<JF'G3ANXM+U:T/S7+JT*.+
MI5:OPQE%OT339^W5?"'_  6.^*23W_A/P9!)N:W$FKW:@]"V8H?QP)OP(KM;
MK_@L+X'3P?\ :(?#WB236S'_ ,>3+$L(DQT,V\G;G^()G_9%?!_Q@^*VK?&W
MXCZIXGUJ17O]4EWLJ?ZN%0 J1J.RJH '?C)R<FOQ[@;@_&T<Q^N8ZFX1IWM?
MK)Z?<E=W[VL?T5XH>(>68G)WE^6554E5:NU?W8IWU\VTE;>U[VZ\S7U]_P $
MAOA _B+XKZQXRN(?]#\.VOV2V<C@W,W!(/\ LQ!@?^NBU\I>$O">H^.O$UCH
M^DVLM]J6I3+;V\$8RTCL<#Z#N2>  2>*_7S]EKX"VO[.'P7TKPS T<UU&IN+
M^X4?\?-R^"[?08"C/\*K7U7B)G<<)ESPD7[]72W:/VG\]OGY'P?A!PS/,,XC
MCZB_=4/>OT<_LKU7Q>5EW1^,7_!PUX!F\)?\%"9]4:,B'Q1X?L;]'QPQ0/;$
M?4>0/P(]:^%Z_;;_ (.(_P!DFZ^+W[.FC_$C1[5KC4_AS+(-06-<L^G3[0[^
MI\J14;V5Y&Z U^)-?S\C^MV?9W_!"3]I?2_V=OVZ+.VUVZBL=)\=:=)X?:XE
M;;%!</)'+ S'MNDB$>>@,O/'-?OU7\FX.*^I_@Q_P6?_ &B/@AX3M]#T_P <
M?VMIMF@CMTUFRAOI(% P )77S2 , !F( &!BDT-,_H+\=^.]'^&/@[4O$'B#
M4K72-%T>!KJ\O+EPD5O&HR6)_IU)P!DFOYP?^"C7[7TW[;O[6'B+QLJS0Z+E
M=.T2WEX:"QAR(\CLSDO(PYPTK#H*H_M._P#!0/XO?MA11V_C[QGJ&JZ;"XDB
MTV%([2Q1AT8PQ*JLP[,X9AD\UY+HN@7WB.YDAT^SN;V:&WENI$@C+LD,4;22
MR$#HJ(K,QZ *2::5@;*=?LE_P3+^&$O@C_@A'\5-5CC9;OQEH_B?4XV ^9@E
ME):)^&;9B/J:_&VOZ6OV-?@5;>$_^"?G@+P'J$.R*X\'P6FH1@?\M+FWW7 _
M[[EDH81/YI:Z;X*>'(?&/QE\(Z1<;?L^J:U9V<N>FV2=$/Z&F_&#X7ZG\$_B
MKXB\(:S$T.J>&M1GTZY4C +Q.5W#_9;&0>X(-8>D:M<:#JUK?6<S6]W9S)/!
M*OWHW4AE8>X(!IDG]8 &T8'05P7[47QXT_\ 9C_9[\7>/-3,?V?PSILMVD<C
M;1<S8VPPY]9)2B#W:OA3X*?\')7PUO?AI9MX^\,>+]/\66\"K>)I%K!=6=W(
M!@O$SS(RAB,[7'RYQN;&:^)_^"H/_!777?V_?LOAO1]-G\+?#W39Q<I8R3"2
MZU.89"RW!7Y0%!.V-<@$DEF.W;/*7S'N6B_\'-WC>#;_ &C\+_"MUZ_9M2GM
M\_\ ?0>OI3_@GG_P6MU;]O+]H&T\"6_PE_L9/LD]_?ZK'XA-Q'801K]XQ&V4
MG=(T: ;QS(#VK\,XXVFD5$5F9CA5 R2?05^]W_!%7]@:3]BW]G*X\2>*K46?
MCCQPB7NH),,/I5FH)AMFS]U@&9Y!QAF"G_5@T.PE<_,'_@MS\3?^%F?\%)/'
MWER>9:^'_LNBP<_=\FWC\P?]_FEKY-KK/CW\1G^,'QR\9>+)&9F\3:W>:IEN
MO[Z=Y /P#8KDZHD_>#_@WG^&7_"#_P#!/F#6&CVR>,=>O=3#$<M'&4M%'TS;
MN?Q-?6'[3'Q,'P9_9U\=>+?,\MO#>@7VHQG/5XH'= /<L ![FN7_ ."?OPR_
MX4[^Q'\+/#K1^3/9>&[.2Y3&-L\L8FF'_?R1Z\A_X+I_$W_A7'_!-WQE#')Y
M=UXFN+/183GKYDZR2#\88I1^-1U-.A_/JS%FR>2>23WK2\'>&+GQOXNTO1;-
M=UYJ]Y#90+ZR2.$4?FPK-KZ(_P""3?PR_P"%L_\ !13X4Z:T?F16>M+J\@(R
MH6S1[KGV)A _&K,S^B_PAX9MO!7A/2]'LEV6>DVD5E O]V.- BC\@*T:KZQJ
M]KX?TBZO[ZXAM+*QA>XN)Y6"QPQH"S.Q/   ))[ 5\I:O_P4<U34M1M[G2]/
M\ ^&]&U"VAO])3QEK]SIM_J]G-(\=O=,D5K+'9PSLC"(SN68#)1.E9FA]:T5
MYI\'OVH-#^)>@WS:HG_"'^(=#OGTO6=%U6YB6XTZZ14<J&!VRQM')'(DB?*Z
M2*>#D H _.S]MCX(R>#?VUM4TCRVBL_%6I17]HV,!TNI/FQ])3(O_ :^I/\
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M9;ON^[?5O5A1116)T!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
:444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
